• Conference Recording
  • On-Demand
  • Pharmacotherapy
Rather than weight/BMI, body composition is a better way for individualized assessment of metabolic health in a patient.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Surgery
This talk will focus on minimally-invasive weight loss procedures known as the endoscopic bariatric therapies (“endobariatrics”).
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Practice Management
This session will discuss strategies to increase access to obesity care while mitigating provider burnout.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Treatment Strategies
Obesity medicine clinicians routinely care for patients with diabetes and treatment often results in significant changes in blood glucose and is associated with a high risk for hypoglycemia.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Physical Activity
The purpose of this presentation is to provide attendees with simple, clear, evidence-based information on clinically safe exercise programming.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Nutrition Therapy
Nutrition plays a crucial role in managing obesity. Three approaches have garnered attention for their effectiveness.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Pharmacotherapy
In this co-presentation, we will explore the fascinating link between body composition changes, the use of anti-obesity medications, and the innovative approach of clinician-led obesity care.
  • 1.25 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Treatment Strategies
The purpose of this session is to help the obesity care specialist advocate for the integration of obesity medicine into a metabolic and bariatric surgery practice by detailing the potential benefi
  • 1.25 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Pediatrics
  • Pharmacotherapy
CME/CE Expiration Date: 4/26/27*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.   
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Pharmacotherapy
This session will inform HCPs on the tirzepatide molecule, the SURMOUNT global trial program for the treatment of obesity and overweight, and the safety and efficacy data disclosure for SURMOUNT-3
  • 1.00 AMA PRA Category 1 Credit

Pages